Investors

In this section of the Rock Creek Pharmaceuticals Investor pages, you'll find our news releases. The releases are listed in chronological order and are archived by year.

Archives: Search / 2016 / 2015 / 2014

2016 Archives

Aug 11, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, filed...

More
Jul 8, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions,...

More
Jun 1, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions,...

More
May 16, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, today...

More
May 5, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions,...

More
Mar 22, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, today...

More
Mar 1, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat acute and chronic inflammatory...

More
Feb 3, 2016

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage drug development company which is focused on the application of its lead compound to treat acute and chronic inflammatory...

More
Jan 5, 2016
Web Link Provided Below

Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage drug development company which is focused on the application of its lead compound to treat chronic inflammatory conditions,...

More
 

print email rss